Several studies support a role for AhR ligands as inhibitors of breast cancer and this includes some studies in this laboratory on TCDD and related compounds as antiestrogens associated with ligand-dependent inhibitory AhR-ERα crosstalk [20,21,22]. Here, AHR is linked to breast carcinoma.